About Us
TWi USA
USA Team
Our Products
For Customers
Authorized Distributors
TWi USA State Licenses
Return Goods Policy
Customer Service Contacts
For Patients
Adverse Event Reporting, Product Complaints & Medical Information(FOr USA Only)
Sorafenib Co-Pay Savings Program
Contact Us
buPROPion Hydrochloride Extended-Release Tablets (XL)
Cyclobenzaprine Hydrochloride Extended-Release Capsules
Diltiazem Hydrochloride Extended-Release Capsules
Dimethyl Fumarate Delayed-Release Capsules
Donepezil tablets
Fenofibric Acid Delayed-Release Capsules
Fluphenazine Hydrochloride Tablets, USP
Guanfacine Hydrochloride Extended-Release Tablets
Hydroquinone Cream
MegestrolAcetate Oral Suspension
Metformin Hydrochloride Extended Release Tablets
Metoprolol Succinate Extended-Release Tablets
Mycophenolic Acid DR Tablets
Nifedipine Extended-Release tablets
Paclitaxel Protein-Bound Particles for Injectable Suspension - (Albumin-Bound)
Propafenone Hydrochloride Extended-Release Capsules, USP
Sevelamer Carbonate Tablets
Sorafenib Tablets, USP
Testosterone Gel, 1.62% CIII
Terbutaline Sulfate tablets
Testosterone Topical Solution CIII, USP
Home > Products > For the United States
buPROPion Hydrochloride Extended-Release Tablets (XL)
Route
Oral
Dosage form
Extended Release Tablets
Strength
150mg, 300mg
Rx/OTC
Rx
Indication
Smoking cessation aid and antidepressant.
TE Rating
AB3
Reference Listed Drug
Wellbutrin XL®
ANDA#
210081
Strength
Form
Product Description
Imprint
Image
How Supplied
NDC Number
HDMA
Sheets
PI
SDS
150mg
Extended-Release (XL)
White film coated tablets printed with "T 101" on one side and plain on the other side
T 101
Bottle of 30
24979-101-06
Bottle of 90
24979-101-07
Bottle of 500
24979-101-02
300mg
Extended-Release (XL)
White film coated tablets printed with "T 102" on one side and plain on the other side
T 102
Bottle of 30
24979-102-06
Bottle of 90
24979-102-07
Bottle of 500
24979-102-02
Back
Top